Canadian Medical Marijuana Company Goes Public Next Week

It also tends to look for seats on the boards of those companies. “An investor that seeks exposure to the fast-growing medical marijuana industry would be interested in PharmaCan because it mitigates the risk of investing in the industry,” said Paul Rosen, chief executive of PharmaCan.

“We’ve created a diversified, regionally based portfolio of licensed producers,” he added. “We’re the only company in Canada that has this significant an investment in this many licensed producers.” PharmaCan’s stable of licensed medical marijuana producers includes British Columbia-based Whistler Medical Marijuana Co and Simcoe County, Ontario-based Peace Naturals Project. PharmaCan also owns 100 percent of In The Zone Produce, a licensed producer based in Okanagan Valley, British Columbia.

Buying into the company means an investor does not have the hassle of trying to decide which licensed producer to invest in, said Daniel Pearlstein, life sciences analyst at M Partners. He said PharmaCan’s listing could benefit the broader industry. Marijuana companies that have gone public this year include T-Bird Pharma Inc , Tweed Marijuana Inc , OrganiGram Holdings Inc and Bedrocan Cannabis Corp . Earlier this week, Leamington, Ontario-based Aphria Inc listed on the venture exchange.

To read more, visit–sector.html

Comments are closed.

Get the latest content first.
©Marijuana Stocks Report